Yanqi Dang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Pharmacology top 10%
Papers in
-
- Epigenetics and DNA Methylation 6
- Gut microbiota and health 6
- RNA modifications and cancer 4
- Peroxisome Proliferator-Activated Receptors 4
- Cancer-related gene regulation 3
- Epidemiology 15
- Liver Disease Diagnosis and Treatment 14
- Co-authors
- Guang Ji (30 shared papers)Wenjun Zhou (18 shared papers)Zhenhua Yang (3 shared papers)Wenjun Zhou (5 shared papers)Mingzhe Zhu (7 shared papers)Li Zhang (5 shared papers)Yangxian Xu (5 shared papers)Meng Li (5 shared papers)
In The Last Decade
Yanqi Dang
38 papers receiving 871 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 171
- Pharmacology 69
- Molecular Biology 494
- Epidemiology 249
- Hepatology 56
Countries citing papers authored by Yanqi Dang
This map shows the geographic impact of Yanqi Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqi Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqi Dang more than expected).
Fields of papers citing papers by Yanqi Dang
This network shows the impact of papers produced by Yanqi Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqi Dang. The network helps show where Yanqi Dang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanqi Dang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 83 | |
| 2 | 2022 | 72 | |
| 3 | 2022 | 65 | |
| 4 | 2019 | 64 | |
| 5 | 2020 | 45 | |
| 6 | 2022 | 34 | |
| 7 | 2024 | 34 | |
| 8 | 2020 | 33 | |
| 9 | 2019 | 30 | |
| 10 | 2022 | 29 | |
| 11 | 2020 | 29 | |
| 12 | 2020 | 29 | |
| 13 | 2021 | 29 | |
| 14 | 2020 | 28 | |
| 15 | 2022 | 27 | |
| 16 | 2021 | 25 | |
| 17 | 2015 | 24 | |
| 18 | 2015 | 23 | |
| 19 | 2019 | 23 | |
| 20 | 2023 | 19 |
About Yanqi Dang
Yanqi Dang is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Oncology and Surgery, having authored 41 papers that have together received 878 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (14 papers), Cancer-related molecular mechanisms research (7 papers), Epigenetics and DNA Methylation (6 papers), Gut microbiota and health (6 papers), RNA modifications and cancer (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (171 citations), Pharmacology (69 citations), Molecular Biology (494 citations), Epidemiology (249 citations) and Hepatology (56 citations). Yanqi Dang has collaborated with scholars based in China, Canada and Singapore. Frequent co-authors include Guang Ji, Wenjun Zhou, Zhenhua Yang, Wenjun Zhou, Mingzhe Zhu, Li Zhang, Yangxian Xu, Meng Li, Pan Ma and Guo‐Qiang Lin. Their work appears in journals such as Biomedicine & Pharmacotherapy, Journal of Ethnopharmacology, Frontiers in Pharmacology, World Journal of Gastroenterology and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.